| Notation | Art |
|---|
| Adult | MESH |
| Antineoplastic Agents, Hormonal/therapeutic use | MESH |
| Antineoplastic Combined Chemotherapy Protocols/therapeutic use | MESH |
| Brain Stem Neoplasms/surgery | MESH |
| Cerebellar Neoplasms/surgery | MESH |
| Chemotherapy, Adjuvant | MESH |
| Cisplatin/administration & dosage | MESH |
| Combined Modality Therapy | MESH |
| Cranial Irradiation | MESH |
| Female | MESH |
| Hemianopsia/etiology | MESH |
| Humans | MESH |
| Lomustine/administration & dosage | MESH |
| Medulloblastoma/surgery | MESH |
| Neoplasms, Hormone-Dependent/secondary | MESH |
| Octreotide/therapeutic use | MESH |
| Optic Nerve Neoplasms/secondary | MESH |
| Purpura, Thrombotic Thrombocytopenic/etiology | MESH |
| Radiotherapy, Adjuvant | MESH |
| Receptors, Somatostatin/analysis | MESH |
| Salvage Therapy | MESH |
| Somatostatin | MESH |
| Vincristine/administration & dosage | MESH |